Screener
Oric Pharmaceuticals, Inc. ORIC Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Oric Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
FAQ
- What is Oric Pharmaceuticals, Inc.'s debt-to-equity?
- Oric Pharmaceuticals, Inc. (ORIC) reported debt-to-equity of 0× in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s debt-to-equity changed year-over-year?
- Oric Pharmaceuticals, Inc.'s debt-to-equity decreased by 45.9% year-over-year, from 0× to 0×.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s debt-to-equity has grown at a -19.2% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Oric Pharmaceuticals, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude